Bernd Schmidt
Director Técnico/Científico/I+D en SENSORION .
Cargos activos de Bernd Schmidt
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| SENSORION | Director Técnico/Científico/I+D | 11/12/2023 | - |
Historial de carrera de Bernd Schmidt
Antiguos cargos conocidos de Bernd Schmidt.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Quell Therapeutics Ltd.
 Quell Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Quell Therapeutics Ltd. is a London-based biotechnology company, which develops immune cell therapies to target transplant rejection, autoimmune and inflammatory diseases. It develops engineered T regulatory cell therapies for a variety of non-cancer targets. The company was founded on March 19, 2019 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - | - |
Formación de Bernd Schmidt.
| Friedrich-Alexander University of Erlangen-Nuremberg | Graduate Degree |
Estadísticas
Internacional
| Alemania | 2 |
| Reino Unido | 2 |
| Francia | 2 |
Operativa
| Graduate Degree | 1 |
| Corporate Officer/Principal | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SENSORION | Health Technology |
| Empresas privadas | 1 |
|---|---|
Quell Therapeutics Ltd.
Quell Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Quell Therapeutics Ltd. is a London-based biotechnology company, which develops immune cell therapies to target transplant rejection, autoimmune and inflammatory diseases. It develops engineered T regulatory cell therapies for a variety of non-cancer targets. The company was founded on March 19, 2019 and is headquartered in London, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Bernd Schmidt
- Experiencia
